T. Rowe Price Health Care ETF
TMEDNASDAQT. Rowe PriceEquity
As of Oct 16, 2026 close
- Assets (AUM)
- $32.36M
- Expense ratio
- 0.44%
- Dividend yield
- 0.48%
- Holdings
- 120
- 52-week range
- $27.60$36.72
- Volume (live)
- -
- Avg. volume (3M)
- 5.98K
TMED ETF: T. Rowe Price Health Care ETF - Price, Holdings & Analysis
T. Rowe Price Health Care ETF Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fund characteristics, expense ratio, dividend yield, and performance metrics
| Day's Range | $33.30 - $33.74 |
|---|---|
| 52-Week High | $36.72 |
| 52-Week Low | $27.60 |
| Open | $33.74 |
| Volume (last close) | 6.22K |
| Average Volume (3M) | 5.98K |
| 1 Day Change | +2.12% |
|---|---|
| 1 Month Change | −1.07% |
| 6 Month Change | +10.17% |
| YTD Change | +14.19% |
| 1 Year Change | +20.68% |
| Annual Dividend | $0.16 |
|---|---|
| Dividend Yield | 0.48% |
| Last Dividend Ex-Date | Dec 23, 2025 |
| Assets (AUM) | $32.36M |
|---|---|
| Expense Ratio | 0.44% |
| Total Holdings | 120 |
| Inception Date | Jun 10, 2025 |
| 50-Day MA | $34.65 |
|---|---|
| 200-Day MA | $31.85 |
| RSI | 39.92 |
| Stochastic %K | 23.57 |
| Stochastic %D | 28.84 |
Source: Exchange price data and fund disclosures. Data as of Oct 16, 2026. Data sources and methodology
TMED at a Glance
T. Rowe Price Health Care ETF (TMED) is an equity ETF from T. Rowe Price, launched in June 2025. It manages $32.36M in assets and charges a 0.44% expense ratio, about $44 a year per $10,000 invested.
As of its Oct 4, 2026 holdings, it holds 120 positions. The largest are Eli Lilly and Company (LLY, 12.08%), Alnylam Pharmaceuticals, Inc (ALNY, 5.81%) and UnitedHealth Group Incorporated (UNH, 5.53%). The top 10 holdings make up 45.8% of the fund. By sector it leans toward Healthcare (100.0%). 95.4% of assets are in the United States.
It pays distributions yielding 0.48% at the Oct 16, 2026 close, $0.16 per share over the trailing 12 months. As of the Oct 16, 2026 close, the share price is up 20.7% over one year (price change, excluding distributions).
Frequently Asked Questions About T. Rowe Price Health Care ETF
What is the current price of TMED?
The latest TMED price is $33.33 (Oct 16, 2026 close). The 52-week range is $27.60–$36.72. The share price is up 20.7% over the past year (price change, excluding distributions).
What is the expense ratio for TMED?
TMED's annual expense ratio is 0.44%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equity ETFs in the ETF Screener.
Does TMED pay dividends?
Yes, TMED pays a 0.48% dividend yield (trailing 12 months, at the Oct 16, 2026 close). The most recent ex-dividend date was December 23, 2025. View full dividend history in the Dividends section.
What are the top holdings of TMED?
As of Oct 4, 2026, TMED's largest holdings are Eli Lilly and Company (12.1%), Alnylam Pharmaceuticals, Inc (5.8%), UnitedHealth Group Incorporated (5.5%) (combined weight: 23.4%). The fund holds 120 total positions. View the complete portfolio breakdown in the Holdings section.
How does TMED compare to similar ETFs?
Compare TMED (0.44% expense ratio, $32M AUM) against similar Equity ETFs using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.